Neogenomics (NEO) FCF Margin Growth (1y) (2011 - 2026)
Neogenomics (NEO) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 379.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 183.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1,284.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 454.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 97.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -192.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -537.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 590.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -71.00 |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | -190.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -190.00 |
| Mar 31, 2026 | 1,071.00 |
| Dec 31, 2025 | -239.00 |
| Sep 30, 2025 | 123.00 |
| Jun 30, 2025 | 723.00 |
| Mar 31, 2025 | 241.00 |
| Dec 31, 2024 | -794.00 |
| Sep 30, 2024 | 550.00 |
| Jun 30, 2024 | 665.00 |
| Mar 31, 2024 | -368.00 |
| Dec 31, 2023 | 1,282.00 |
| Sep 30, 2023 | 1,230.00 |
| Jun 30, 2023 | 1,566.00 |
| Mar 31, 2023 | 1,532.00 |
| Dec 31, 2022 | 1,934.00 |
| Sep 30, 2022 | 2.00 |
| Jun 30, 2022 | -314.00 |
| Mar 31, 2022 | -2,001.00 |
| Dec 31, 2021 | -2,088.00 |
| Sep 30, 2021 | -1,290.00 |